ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "CD T cells"

  • Abstract Number: 492 • 2013 ACR/ARHP Annual Meeting

    Distinction Between Glucocorticoid-Responders and Non-Responders In Rheumatoid Arthritis: A New Role For Endoplasmic Reticulum Aminopeptidase 2

    Ruth Fritsch-Stork1, Sandra Cardoso1, Jasper Broen1, Marian Groot-Koerkamp2, Arno Concepcion1, Floris Lafeber1 and Johannes W.J. Bijlsma1, 1Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Molecular Cancer Research, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: Glucocorticoids (GC) have been a cornerstone of Rheumatoid arthritis (RA)-therapy for the last decades. However, about a third of RA-patients do not respond adequately.…
  • Abstract Number: 2503 • 2012 ACR/ARHP Annual Meeting

    CD8+Foxp3-CD103+ Regulatory T Cells Generated Ex Vivo with TGF-β Suppress Autoimmunity Through IL-10-Dependet Mechanism

    Ya Liu1, An-Ping Xu2, David A. Horwitz3 and Song G. Zheng4, 1Medicine, USC Keck School of Medicine, Los Angeles, CA, 2Kidney disease and rheumatology, 2nd Affiliated Hospital of Sun Yat-sen University, 3Medicine-Rheumatology-Immun, Keck School of Medicine of USC, Los Angeles, CA, 4Medicine, Keck School of Medicine of USC, Los Angeles, CA

    Background/Purpose: TGF-β is crucial for induction of CD4+Foxp3+ Tregs and maintenance of immunologic tolerance. It is, however, unclear if TGF-β also induces the similar CD8+…
  • Abstract Number: 2310 • 2012 ACR/ARHP Annual Meeting

    Enhancement of CRACM1 Expression in Functionally Aberrant Naïve CD4+ T Cells in Active Rheumatoid Arthritis

    Shuang Liu1, Shohei Watanabe2, Miyuki Kuno3, Hiromasa Miura2 and Kazutaka Maeyama1, 1Department of Pharmacology, Informational Biomedicine, Ehime University Graduate School of Medicine, Toon-shi, Ehime, Japan, 2Department of Bone and Joint Surgery, Ehime University Graduate School of Medicine, Toon, Japan, 3Department of Molecular and Cellular Physiology, Osaka City University Graduate School of Medicine, Osaka, Japan

    Background/Purpose: Lymphocytes from rheumatoid arthritis (RA) patients have been reported to exhibit increased basal intracellular Ca2+ concentrations compared with the lymphocytes of healthy controls.  A…
  • Abstract Number: 2313 • 2012 ACR/ARHP Annual Meeting

    The Autoantibody-Inducing CD4 T Cell (aiCD4 T cell) Belongs to CCR4+CD45RBlo122lo CD4 Subpopulation: A Novel ‘Self-Organized Criticality Theory’ Explains the Cause of Systemic Lupus Erythematosus (SLE)

    Yumi Miyazaki1, Ken Tsumiyama2 and Shunichi Shiozawa2, 1Kyushu University Beppu Hospital/ Kobe University Graduate School of Health Sciences, Beppu/ Kobe, Japan, 2Kyushu University Beppu Hospital, Beppu, Japan

    Background/Purpose:  We found that systemic lupus erythematosus (SLE) was induced experimentally by repeatedly immunizing the mice normally not prone to autoimmune diseases by any exogenous…
  • Abstract Number: 2269 • 2012 ACR/ARHP Annual Meeting

    The Differences of DNA Methylome and Transcriptome Among Diverse Clinical Manifestations of Systemic Lupus Erythematosus

    Ming Zhao1, Shuangyan Luo1, Honglong Wu2, Siyang Liu2, Meini Tang1, Wenjing Cheng1, Qing Zhang1, Xinhai Yu1, Tak Mao Chan3, Yudong Xia2, Na Yi2, Fei Gao2, Li Wang2, Ning Li2 and Qianjin Lu4, 1Department of Dermatology, Second Xiangya Hospital, Central South University; Hunan Key Laboratory of Medical Epigenomics, Changsha, China, 2Beijing Genomics Institute at Shenzhen, Shenzhen, China, Shenzhen, China, 3Division of Nephrology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China, 4Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, China

    Background/Purpose: Aberrant DNA methylation and gene expression have been observed in systemic lupus erythematosus (SLE). However, patterns of DNA methylation and gene expression associated with…
  • Abstract Number: 1439 • 2012 ACR/ARHP Annual Meeting

    CTL-Promoting Effects of IL-21 Results in B Cell Elimination and Disease Improvement in a Murine Model of Lupus

    Vinh Nguyen1, Daniel Veizaga-Udaeta2, Horea Rus3 and Violeta Rus4, 1Medicine, University of Maryland School of Medicine, Baltimore, MD, 2University of Maryland at Baltimore County, MD, 3Neurology, University of Maryland School of Medicine and Veteran Affairs Medical Center, Baltimore, MD, 4Medicine, University of Maryland School of Medicine and Veteran Affairs Medical Center, Baltimore, MD

    Background/Purpose: IL-21 is a member of the type I cytokine family with pleiotropic activities. IL-21 enhances CD8 T cells maturation into cytotoxic T lymphocytes (CTL),…
  • Abstract Number: 429 • 2012 ACR/ARHP Annual Meeting

    The Significance of the Apoptosis Level and the Apoptosis Related Signal Proteins of CD4+t�ACD4+Foxp3+t Cell in Patients with Rheumatoid Arthritis

    Ning Li1, Tianrui Ma2, Jie Han1, Jieru Zhou1 and Songguo Zheng3, 1Rheumatology, Shanghai East Hospital, Shanghai, China, 2Rheumatology, Ningbo Pediatric Hospital, Ningbo, China, 3Division of Rheumatology and Immunology, Department of Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA

    Background/Purpose: To investigate the apoptosis of CD4+T cell and Tregs in the pathogenesis and disease activity of rheumatoid arthritis patients. Methods: Isolated lymphocytes from human…
  • « Previous Page
  • 1
  • 2
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology